A clinical & scientific perspective on lecanemab – UK DRI Roundtable
Did you know the EU rejects Alzheimer's drug lecanemab?
New drug can slow the development of Alzheimer's
Making and Unmaking Dementia: A History and a Future
Smart New Ways to Diagnose Dementia
In Conversation 2022
Getting to know the 'Dementias Platform UK' data portal - LIVE Podcast Recording
Dementias Platform UK supporting researchers worldwide
iSCAN 2021 - Session 1: Karen Duff, Lili Liu, Stefan Remy & Motoharu Yoshida
The New Alzheimer’s Drug: What is Leqembi?
What is the controversy over Aducanumab/Aduhelm for Alzheimer's?
Why is the FDA approving dangerous drugs?
Dr Sam Moxon - How to Develop Research Independence
Ask Your Mentor - Professor Patrick Lewis
Ask Your Mentor - Dr Yvonne Couch
June 9, 2023 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
The Changing Outlook for Alzheimer's in 2024
Dr Kamar Ameen-Ali - Pivoting your research area
Dr Yvonne Couch - Money Management - Planning your research budget
Blood Based Biomarkers for Dementias